CALIPSO: Calcified Lesions and Use of OCT

Percutaneous coronary intervention (PCI) in calcified lesions remains one of the most challenging scenarios in daily practice, as these lesions are often accompanied by stent underexpansion, malapposition, perforation, and high rates of reintervention.

In this context, optical coherence tomography (OCT) has emerged as a key tool, capable of quantifying calcium burden and thickness, guiding proper plaque preparation, optimizing stent sizing, and improving implantation strategy. However, randomized evidence on OCT-guided PCI in calcified disease remains limited.

The CALIPSO study, published by Amabile N. et al., aimed to assess whether an OCT-guided PCI strategy, combined with standardized algorithms for plaque preparation, stent selection, and post-implantation optimization, could achieve greater luminal expansion (measured as minimum stent area, MSA) compared with standard angiography-guided PCI in calcified lesions.

This was an open-label, multicenter, 1:1 randomized study conducted in 12 centers across France that included patients with chronic coronary syndrome (CCS) and a target lesion with angiographically moderate or severe calcification. In both groups, a post-PCI OCT acquisition was performed to assess the MSA.

Read also: Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies.

A total of 134 patients were analyzed for the primary endpoint (65 OCT; 69 angiography). The primary outcome showed a significant advantage in favor of OCT: the mean MSA was 6.5 mm² vs. 5.0 mm² with angiography (p <0.001). The proportion of patients with MSA ≤4.5 mm² was significantly lower with OCT (8% vs. 36%; p <0.001). Similarly, the mean stent area was larger with OCT (8.4 vs. 7.4 mm²; p <0.001). These differences that remained consistent across subanalyses according to calcium severity and extent.

The OCT-guided strategy also promoted earlier and more targeted use of plaque modification devices: intravascular lithotripsy (IVL) was used as a first-line tool in 46% of cases (vs. 12% in the angiography group; p <0.001), with a lower need for bailout interventions (6% vs. 20%; p = 0.02). The incidence of periprocedural complications was similar between groups, although there was a trend toward greater malapposition in the angiography group.

Read also: Safety of Prophylactic Spinal Fluid Drainage in Open and Endovascular Repair of Thoracic and Thoracoabdominal Aortic Aneurysms.

In 43% of cases in the OCT arm, the first post-PCI assessment prompted additional optimization maneuvers, increasing the mean MSA from 5.9 to 7.2 mm² (p <0.001). Even before these additional steps, MSA values were already higher compared with angiography guidance.

Conclusion

In patients with CCS and moderate-to-severe calcified lesions, an OCT-guided PCI strategy using standardized algorithms achieves greater luminal expansion (MSA) compared with angiography. The CALIPSO study supports the systematic adoption of intracoronary imaging as a key tool for optimal plaque preparation and stent implantation in this complex clinical setting.

Original Title: OCT vs Angiography for Guidance of Percutaneous Coronary  Intervention of Calcified Lesions The CALIPSO Randomized Clinical Trial

Reference: Amabile N, Rangé G, Landolff Q, Bressollette E, Meneveau N, Lattuca B, Levesque S, Boueri Z, Adjedj J, Casassus F, Belfekih A, Veugeois A, Souteyrand G, Honton B. OCT vs Angiography for Guidance of Percutaneous Coronary Intervention of Calcified Lesions: The CALIPSO Randomized Clinical Trial. JAMA Cardiol. 2025 Jul 1;10(7):666-675. doi: 10.1001/jamacardio.2025.0741. PMID: 40305015; PMCID: PMC12044539.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...